Results 161 to 170 of about 10,096 (214)

Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary. [PDF]

open access: yesGynecol Oncol
Washington C   +15 more
europepmc   +1 more source

Association between current major depressive episode and the occurrence of menstrual irregularities in the last six months in university students in Lima, Peru. [PDF]

open access: yesRev Peru Med Exp Salud Publica
Pantoja-Coronel X   +5 more
europepmc   +1 more source

Maternal environmental enrichment affects the corpora lutea and progesterone levels in pregnant mice. [PDF]

open access: yesFront Endocrinol (Lausanne)
De la Cruz Borthiry FL   +6 more
europepmc   +1 more source

[Evolution of Surgical Outcomes in Spinal Metastases from Solid Tumors: A Comparative Analysis over 2 Decades]. [PDF]

open access: yesRev Bras Ortop (Sao Paulo)
Silva FPDSFD   +5 more
europepmc   +1 more source

Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer - a plain language summary. [PDF]

open access: yesFuture Oncol
González-Martín A   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy